MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4892 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-01-26 (jomfruland.net)
Consider twice before you invest! Discover today's safe shares with yield -
Investing in stock shares can be a deterrent task. Although the attraction of high dividend yields is tempting, the basic stability of the company's business model is crucial. In 2023, susceptible investors should focus their attention on companies with resistant operations, not just on attractive revenues. Two companies illustrate this difference: Medtronic and Medical Properties Trust. Medtronic is characterized as a front name in the field of medical devices. Known with its innovative products, it operates in more than 150 countries and covers various therapeutic areas. Although its recent income growth has been mild, Medtronic is located on the threshold of significant progress. Its segment of care for diabetes with
Read more
2025-01-16 (insiderpaper.com)
A Look at Current Technologies Advancing Pain Management Care -
Science is always evolving, which can make it feel like new treatments are always on the horizon. As patients, it can be encouraging
Read more
2024-11-20 (cardiovascularnews.com)
ALERT study to use AI to identify underserved patients eligible for TAVI
Medtronic has announced the launch of a randomised study—ALERT—aiming to address the undertreatment of severe aortic stenosis or moderate-to-severe or severe mitral regurgitation.
Read more
2024-10-16 (medicaldevice-network.com)
Boston Scientific: evolving the cardiac rhythm management space
The CRM space is comprised of devices that are used to restore the natural synchronised pumping rhythm of the heart.
Read more
2024-10-05 (market.us)
Pain Management Devices Market to Hit $9.4 Billion by 2032
Pain Management Devices Market Size is expected to reach USD 9.4 Billion by 2032 from USD 4.4 Billion in 2022, at a CAGR of 8.1% (2023-2032).
Read more
2024-09-13 (market.us)
Neurostimulation Devices Market on Path to $36.5 Billion
Neurostimulation Devices Market Size is expected to reach USD 36.5 Bn by 2032 from USD 11.1 Bn in 2022, at a CAGR of 13% (2023-2032).
Read more
2024-08-10 (whatech.com)
Implantable Loop Recorder Market The Growing Adoption of Implantable Loop Recorders: A Comparative Analysis of Market Penetration, Reimbursement Landscape, and Patient Acceptance.
Implantable Loop Recorder Market to reach over USD XX billion by the year 2031,
Read more
2024-04-24 (bmj.com)
Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification
Background The Chicago Classification (CC) defines oesophagogastric junction outflow obstruction (EGJOO) as the presence of an elevated integrated residual pressure (IRP) together with preserved oesophageal body peristalsis but its clinical significance is evolving. Aims To describe the clinical and
Read more
2024-02-27 (ibtimes.com)
50 Top Companies By Market Capitalization: The Global Giants
These companies are the ones that dominate the market and will continue to do so should factors remain constant.
Read more